1. Study of prognostic factors in multiple myeloma
- Author
-
Kinjalka Ghosh, Nikhil Choudhary, Geeta Rathnakumar, Nitin Inamdar, and Narendra Kamble
- Subjects
medicine.medical_specialty ,Creatinine ,Globulin ,biology ,medicine.diagnostic_test ,Myeloma protein ,Beta-2 microglobulin ,business.industry ,Albumin ,medicine.disease ,Gastroenterology ,chemistry.chemical_compound ,chemistry ,Internal medicine ,Serum protein electrophoresis ,medicine ,biology.protein ,business ,Survival rate ,Multiple myeloma - Abstract
Background: Multiple myeloma (MM) is cancer of the plasma cell characterized by interpatient heterogeneity, in most of the cases it is incurable. It is the second most common hematological malignancy. Overall survival of patients has significantly increased recently. Lot of research is going on for prognostic factors, which can predict disease and response to therapy. During the past decades, biomarkers: M protein and β2 microglobulin have shaped the knowledge about MM. This study was undertaken to evaluate the role of prognostic factors in newly diagnosed and few follow up patients of MM before, during and after the treatment in Indian population.Methods: We analyzed 177 samples (90 MM patients and 87 healthy control) for creatinine, calcium, phosphorus, LDH, total protein, albumin, globulin, β2M, Immunoglobulines (Igs), IgG, IgA, IgM, Kappa light chain and Lambda light chains, serum protein electrophoresis (SPE) and immunofixation electrophoresis (IFE).Results: The result of our study are significant at p
- Published
- 2021
- Full Text
- View/download PDF